Loading...
 
Back to the list
Mediterr J Rheumatol 2016;27(4):161-8
Article Links
Cogan’s syndrome: linking many medical specialties
N. C. Galanopoulos
Authors Information
Outpatient Department of University General Hospital Evros (Alexandroupoli), Thrace, Greece
Keywords: Cogan’s syndrome, Progressive sensorineural hearing loss, hearing loss, vestibuloauditory dysfunction, aortitis, cyclosporine, methotrexate, leflunomide, mycophenolate mofetil, anti-TNFα therapy, infliximab, rituximab
References
  1. Cogan D S. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 1945;3:144.
  2. Haynes B F, Kaiser-Kupfer M I, Mason P, et al. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 1980;59:426.
  3. Vollertsen R S, McDonald T J, Younge B R, et al. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986;61:344.
  4. St Clair E W, McCallum R M. Cogan's syndrome. Curr Opin Rheumatol 1999;11:47.
  5. Migliori G, Battisti E, Pari M, et al. A shifty diagnosis: Cogan's syndrome. A case report and review of the literature. Acta Otorhinolaryngol Ital 2009;29:108-13.
  6. Podder S, Shepherd R C. Cogan's syndrome: a rare systemic vasculitis. Arch Dis Child 1994;71:163.
  7. Fidler H, Jones N S. Late onset Cogan's syndrome. J Laryngol Otol 1989;103:512.
  8. Kasapçopur O, Ashraf M, Caliskan S, et al. Cogan's syndrome: a rare vasculitis in childhood. J Rheumatol 2000;27:1824.
  9. Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002;360:915.
  10. McCallum R M, Allen N B, Cobo L M, et al. Cogan's syndrome: Clinical features and outcomes (abstract). Arthritis Rheum 1992;35(Suppl):S51.
  11. Gluth M B, Baratz K H, Matteson E L, et al. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 2006;81:483.
  12. Mazlumzadeh M, Matteson E L. Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease. Rheum Dis Clin North Am 2007;33:855.
  13. Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004;43:1007.
  14. Cobo L M, Haynes B F. Early corneal findings in Cogan's syndrome. Ophthalmology 1984;91:903.
  15. Negroni L, Tiberio G. Cogan's syndrome. Riv Otoneurooftalmol 1969;44:199.
  16. Cogan D G, Kuwabara T. Late corneal opacities in the syndrome of interstitial keratitis and vestibulo-auditory symptoms. Acta Ophthalmol Suppl 1989;192:182.
  17. Shah P, Luqmani R A, Murray P I, et al. Posterior scleritis--an unusual manifestation of Cogan's syndrome. Br J Rheumatol 1994;33:774.
  18. McCallum R M, Haynes B F. Cogan's syndrome. In: Ocular Infection & Immunity, 1st, Pepose JS, Holland GN, Wilhelmus KR (Eds), Mosby, St. Louis 1996. p.446.
  19. Fisher E R, Hellstrom H R. Cogan's syndrome and systemic vascular disease. Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger). Arch Pathol 1961;72:572.
  20. Rarey K E, Bicknell J M, Davis L E. Intralabyrinthine osteogenesis in Cogan's syndrome. Am J Otolaryngol 1986;7:387.
  21. Schuknecht H F, Nadol J B Jr. Temporal bone pathology in a case of Cogan's syndrome. Laryngoscope 1994;104:1135.
  22. Vinceneux P, Couloigner V, Pouchot J, et al. Autoimmune deafness. Presse Med 1999;28:1904-10.
  23. Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol 2006;126:1012-21.
  24. Broughton S S, Meyerhoff W E, Cohen S B. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 2004;34:544-8.
  25. 25 . Pleyer U, Baykal H E, Rohrbach J M, et al. Cogan I syndrome: too often detected too late? A contribution to early diagnosis of Cogan I syndrome. Klin Monatsbl Augenheilkd 1995;207:3-10.
  26. Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet 2002;360:915-21.
  27. Cochrane A D, Tatoulis J. Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg 1991;52:1166.
  28. Livingston J Z, Casale A S, Hutchins G M, et al. Coronary involvement in Cogan's syndrome. Am Heart J 1992;123:528.
  29. Gelfand M L, Kantor T, Gorstein F. Cogan's syndrome with cardiovascular involvement: aortic insufficiency. Bull N Y Acad Med 1972; 48:647.
  30. Eisenstein B, Taubenhaus M. Nonsyphilitic interstitial keratitis and bilateral deafness (Cogan's syndrome) associated with cardiovascular disease. N Engl J Med 1958;258:1074.
  31. Allen N B, Cox C C, Cobo M, et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med 1990;88:296.
  32. Pinals R S. Cogan's syndrome with arthritis and aortic insufficiency. J Rheumatol 1978;5:294.
  33. Hammer M, Witte T, Mügge A, et al. Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis. J Rheumatol 1994;21:552.
  34. Cremer J, Laas J, Heublein B. A case of coronary stenosis developing after successful aortic valve repair in Cogan's syndrome. Thorac Cardiovasc Surg 1993;41:255.
  35. Tseng J F, Cambria R P, Aretz H T, et al. Thoracoabdominal aortic aneurysm in Cogan's syndrome. J Vasc Surg 1999;30:565.
  36. Raza K, Karokis D, Kitas G D. Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 1998;37:369.
  37. Vella J P, O'Callaghan J, Hickey D, Walshe J J. Renal artery stenosis complicating Cogan's syndrome. Clin Nephrol 1997;47:407.
  38. Vollertsen R S. Vasculitis and Cogan's syndrome. Rheum Dis Clin North Am 1990;16:433.
  39. Marijana T, Nemanja D, Bosnic D, et al. Atypical Cogan's syndrome associated with coronary disease. Branislava I Chin Med J (Engl) 2011;124:3192-4.
  40. Gasparovic H, Djuric Z, Bosnic D, et al. Aortic root vasculitis associated with Cogan's syndrome. Ann Thorac Surg 2011;92:340-1.
  41. Kim J S, Park J B, Joo J C, et al. A Case of Cogan's Syndrome With Angina. Korean Circ J 2010;40:680-3.
  42. Weissen-Plenz G, Sezer O, Vahlhaus C, et al. Aortic dissection associated with Cogans' syndrome: deleterious loss of vascular structural integrity is associated with GM-CSF overstimulation in macrophages and smooth muscle cells. J Cardiothorac Surg 2010;21;1.
  43. Luong Nguyen L B, Warzocha U, et al. Vascular involvement in Cogan's syndrome. A case report. J Mal Vasc 2012;37:19-21. 
  44. Weyn T, Haine S, Conraads V. Cogan's syndrome with left main coronary artery occlusion. Cardiol J 2009;16:573-6.
  45. Gluth M B, Baratz K H, Matteson E L, et al. Cogan syndrome: a retrospective review of 60 patients throughοut a half century. Mayo Clin Proc 2006;81:483-8.
  46. Bicknell J M, Holland J V. Neurologic manifestations of Cogan syndrome. Neurology 1978 Mar;28(3):278-81.
  47. Riku Y, Sakurai H, Fujino M, Mano K. A case of atypical Cogan's syndrome with a steroid-responsive headache and multiple cranial neuropathy as the initial symptoms. Brain Nerve 2011;63(10):1131-5.
  48. Jacob A, Ledingham J G, Kerr A I, et al. Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol 1990;104:889.
  49. Thomas H G. Case report: clinical and radiological features of Cogan's syndrome-non-syphilitic interstitial keratitis, audiovestibular symptoms and systemic manifestations. Clin Radiol 1992;45:418.
  50. Scharl M, Frei P, Fried M, et al. Association between Cogan's syndrome and inflammatory bowel disease: a case series. J Crohns Colitis 2011;5:64-8.
  51. Lydon E J, Barisoni L, Belmont H M. Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission. Clin Exp Rheumatol 2009;27:S144.
  52. Berrettini S, Ravecca F, Bruschini L, et al. Progressive sensorineural hearing loss: immunologic etiology. Acta Otorhinolaryngol Ital 1998;18:33-41.
  53. Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol 2006;126:1012-21.
  54. Bonaguri C, Orsoni JG, Zavota L, et al. Anti-68 kDa antibodies in autoimmune sensorineural hearing loss. Autoimmunity 2007;40:73-8.
  55. Helmchen C, Jäger L, Bόttner U, et al. Cogan’s Syndrome. High resolution MRI indicators of activity. J Vestib Res 1998;8:155-67.
  56. McCallum R M. Cogan's syndrome. In: Current Ocular Therapy, 4th, Franunfelder F T, Hampton R (Eds), WB Saunders, Philadelphia 1993. p.410.
  57. Darougar S, John A C, Viswalingam M, et al. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol 1978;62:709.
  58. Chandler R D. Inclusion conjunctivitis (paratrachoma, chlamydia). In: Current Ocular Therapy, 4th, Fraunfelder F T, Roy F H, Grove J (Eds), WB Saunders, Philadelphia 1995. p.59.
  59. Dev S, McCallum R M, Jaffe G J. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999;106:111.
  60. Semeraro F, Russo A, Duse S, et al. Retinal angiomatosis and cystoid macular oedema in Cogan's syndrome. Optom Vis Sci. 2011;88:E1262-6.
  61. Shahid F L, Mukherjee R, Knapp C. Cogan's syndrome associated with orbital inflammation. Orbit. 2013;32:206-7.
  62. Meikle A W, Tyler F H. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977;63:200.
  63. Tsuno H, Takahashi Y, Yoshida Y, et al. Successful early treatment in a case of Cogan's syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 2012;35:92-6.
  64. Haynes D S, O'Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3.
  65. Riente L, Taglione E, Berrettini S. Efficacy of methotrexate in Cogan's syndrome. J Rheumatol 1996;23:1830.
  66. Pouchot J, Vinceneux P, Bouccara D, et al. Methotrexate as a steroid-sparing agent in Cogan's syndrome: comment on the concise communication by Richardson. Arthritis Rheum 1995;38:1348.
  67. Roat M I, Thoft R A, Thomson A W, et al. Treatment of Cogan's syndrome with FK 506: a case report. Transplant Proc 1991;23:3347.
  68. Matteson E L, Tirzaman O, Facer G W, et al. Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol 2000;109:710.
  69. Xie L, Cai Y, Bao X, Cao L. Leflunomide for the successful management of juvenile Cogan's syndrome. Clin Rheumatol 2009;28:1453-5.
  70. Best C, Thömke F, Hitzler W, et al. Plasmapheresis as effective treatment in chronic active Cogan-I-syndrome. Immunol Lett. 2013;150:87-8.
  71. Peters B R, Wyss J, Manrique M. Worldwide trends in bilateral cochlear implantation. Laryngoscope 2010;120:S17.
  72. Wang J R, Yuen H W, Shipp D B, et al. Cochlear implantation in patients with autoimmune inner ear disease including Cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope 2010;120:2478.
  73. Hautefort C, Loundon N, Montchilova M, et al. Mycophenolate mofetil as a treatment of steroid dependent Cogan's syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477-9.
  74. Coelho D H, Lalwani A K. Medical management of Ménière's disease. Laryngoscope 2008;118:1099.
  75. Fricker M, Baumann A, Wermelinger F, et al. A novel therapeutic option in Cogan diseases? TNF-α blockers. Rheumatol Int. 2007;27:493–495.
  76. Ghadban R, Couret M, Zenone T: Efficacy of Infliximab in Cogan's Syndrome. J Rheumatol 2008,35:2456-2458
  77. Beccastrini E, Emmi G, Squatrito D, et al. Infliximab and Cogan's syndrome. Clin Otolaryngol. 2010;35:441-2.
  78. Orsoni J G, Laganà B, Rubino P, et al. Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report. Orphanet J Rare Dis. 2010;5:1.